Pathfinder

In The News

PRESS RELEASE . Nashville, March 11, 2009

Pathfinder, a medical device company with first to market products for “surgical GPS” of the abdomen, announced that it has hired Skip Goode as President and CEO effective immediately. The full story can be found here.

PRESS RELEASE . Nashville, October 30, 2008

Pathfinder Therapeutics, Inc. (PTI) is pleased to announce that it has closed on a $5.2 million series A financing round led by Hatteras Venture Partners of Research Triangle Park, NC. The full story can be found here.

PRESS RELEASE . Nashville, October 13, 2008

Pathfinder Therapeutics, Inc. (PTI) is pleased to announce that it will be exhibiting at the American Association for the Study of Liver Diseases' (AASLD) 59th annual Liver Meeting in booth #311 from November 1st to November 3rd at the Moscone West Convention Center in San Francisco, CA.

PTI will be exhibiting its FDA-cleared preoperative liver surgical planning software, PlaniSight Linasys.

PRESS RELEASE . Nashville, September 24, 2008

Pathfinder Therapeutics, Inc. (PTI) is pleased to announce it has been awarded a job training grant from Governor Phil Bredesen and Tennessee Department of Labor & Workforce Development Commissioner James Neeley. More information can be found here.

PRESS RELEASE . Nashville, September 23, 2008

Pathfinder Therapeutics, Inc. (PTI) is pleased to announce that it has received 510(k) clearance from the FDA for PlaniSight Linasys, its preoperative liver surgical planning software. The full press release can be accessed here.

PRESS RELEASE . Nashville, August 6, 2008

Pathfinder Therapeutics Inc. (PTI) is pleased to announce their inclusion in the 2008 Edition of the OneMedPlace Investment Research Report. OneMedPlace follows thousands of medical device companies around the world to gather the latest information on innovations in the field of medicine. PTI is one of a select number of companies to have a profile included in the summer 2008 Report. The report can be accessed at http://www.onemedplace.com/register/?offer=digest.

PRESS RELEASE . Nashville, March 7, 2008

Pathfinder Therapeutics, Inc. (PTI) is pleased to announce it has been chosen as a presenter for the SEMDA 2008 Investor Conference. This annual event will take place on Thursday, March 13th, 2008 at the Ritz Carlton Buckhead in Atlanta. This will represent an excellent opportunity to update potential investors on the advancement of PTI’s plan to commercialize its FDA-cleared Surgisight Linasys™ platform for Navigated Abdominal Surgery.

The Southeastern Medical Device Association (SEMDA) Investor Conference is the ideal venue for the company to interact with investors focused on the region.

PRESS RELEASE . Nashville, February 13, 2008

Pathfinder Therapeutics Inc. (PTI) is providing testimony today before a congressional committee. Dr.James D Stefansic, Chief Technology Officer, will appear before the committee this morning on behalf of AdvaMed. The U.S House of Representatives Small Business Subcommittee on Investigations and Oversight has begun hearings entitled, “SBIR: Advancing Medical Breakthroughs.” Dr. Stefansic was invited to appear because of his expertise in the area of SBIR grants, having authored several grant proposals and his experience as Principal Investigator on two SBIR grants at PTI. Further updates regarding this hearing will appear once the testimony is publicly available.

2007 Press Releases

FDA 510K Cleared
December 21, 2007
Linasys is awarded 510K cleared

The Better World Report
September 10, 2007
http://www.enterprise.cam.ac.uk/

Pathfinder Therapeutics Press Release
April 5, 2007
American Hepato-Pancreato-Biliary Association (AHPBA), April 19-22 in Las Vegas

2006 Press Releases

Pathfinder Therapeutics Press Release
October 2, 2006
Pathfinder Therapeutics Receives $1.9 million Grant from National Cancer Institute

The Tennessean
September 25, 2006
Universities See Sharp Drop in Computer Science Majors

Nashville Business Journal
May 26, 2006
Building a Case - Pathfinder nets grant, hunts for more capital

Pathfinder Therapeutics Press Release
October 2, 2006
Pathfinder Therapeutics Presents to Investors at MedTech Insight’s “Investment In Innovation”